April 30, 2020 / 11:35 AM / a month ago

BRIEF-AcelRx Pharmaceuticals Sees Q1 2020 Revenue $400,000

April 30 (Reuters) - AcelRx Pharmaceuticals Inc:

* SEES Q1 2020 REVENUE $400,000

* PRELIMINARY Q1 2020 REVENUES ARE EXPECTED TO BE $0.4 MILLION

* PRELIMINARY CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS ARE EXPECTED TO BE $52.7 MILLION AS OF MARCH 31, 2020

* ACELRX - DUE TO COVID-19 DSUVIA SALES ADVERSELY AFFECTED & YEAR-END 2020 REMS-CERTIFIED FACILITIES & FORMULARY APPROVALS GOALS TO BE RE-EVALUATED Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below